EXTON, Pa., Oct. 22, 2019 /PRNewswire/ -- (Booths #F44 & #F51)—West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today ...
EXTON, Pa., Jan. 12, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the company ...
EXTON, Pa. - West Pharmaceutical Services, Inc. (NYSE:WST) announced today it has reached a definitive agreement to sell manufacturing and supply rights for its SmartDose 3.5mL On-Body Delivery System ...
AbbVie agreed to acquire a device manufacturing facility in Tempe, Ariz., and the rights to the SmartDose 3.5 milliliter drug-delivery system from West Pharmaceutical Services as part of a deal worth ...
West is committed to the continued commercial supply of SmartDose® 3.5mL On‑Body Delivery System along with the execution of ongoing critical project execution commitments prior to close, which ...
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, announced that the company has reached a definitive agreement to sell all manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results